Departmental Publications

2015 Publications


  1. Hooper JE, Cantor EL, Ehlen MS, Banerjee A, Malempati S, Stenzel P, Woltjer R, Gandour-Edwards R, Goodwin NC, Yang Y, Kaur P, Bult CJ, Airhart SD, Keller C. A patient-derived xenograft model of parameningeal embryonal rhabdomyosarcoma for preclinical studies. Sarcoma 2015 Dec; article ID 826124:7 pages.


  1. Baras AS, Mitchell CJ, Myers JR, Gupta S, Weng LC, Ashton JM, Cornish TC, Pandey A, Halushka MK. miRge - a multiplexed method of processing small RNA-Seq data to determine microRNA entropy. PLoS One 2015 Nov 16;10(11):e0143066 (eCollection 2015).
  2. Cornish TC, Chakravarti A, Kapoor A, Halushka MK. HPASubC: A suite of tools for user subclassification of human protein atlas tissue images. J Pathol Inform. 2015 Jun 23;6:36.
  3. Das S, Halushka MK. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol. 2015 Jul-Aug;24(4):199-206.
  4. Gniadek TJ, Singer N, Barker N, Spevak PJ, Crain BJ, Valle D, Halushka MK. Cardiovascular pathologies in mucopolysaccharidosis type VII (Sly Syndrome). Cardiovasc Pathol 2015 Sep-Oct;24(5):322-6.
  5. Halushka MK, Eng G, Collins AB, Judge DP, Semigran MJ, Stone JR. Optimization of serum immunoglobulin free light chain analysis for subclassification of cardiac amyloidosis. J Cardiovasc Transl Res. 2015 Jun;8(4):264-8.
  6. Maleszewski JJ, Tazelaar HD, Horcher HM3, Hinkamp TJ, Conte JV, Porterfield JK, Halushka MK. IgG4-related disease of the aortic valve: a report of two cases and review of the literature. Cardiovasc Pathol. 2015 Jan-Feb;24(1):56-9703 860 6510.


  1. Jialal I, Sokoll LJ. Clinical utility of lactate dehydrogenase: a historical perspective. Am J Clin Pathol. 2015 Feb;143(2):158-9.
  2. Li QK, Chen L, Ao MH, Chiu JH, Zhang Z, Zhang H, Chan DW. Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers. Theranostics. 2015 Jan 1;5(3):267-76.
  3. Li Y, Shah P, De Marzo AM, Van Eyk JE, Li Q, Chan DW, Zhang H. Identification of glycoproteins containing specific glycans using a lectin-chemical method. Anal Chem 2015 May;87(9):4683-7.
  4. Marzinke MA, Petrides AK, Steele K, Schweitzer MA, Magnuson TH, Reinblatt SP, Coughlin JW, Clarke W. Decreased escitalopram concentrations post-roux-en-Y gastric bypass surgery. Ther Drug Monit. 2015 Jun;37(3):408-12.
  5. Peake RW, Hartigan CR, Esposito CL, Kellogg MD, Gabler J, Wang S, Breaud A, Di Bussolo J, Moskowitz J, Clarke W. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2015 Apr;37(2):161-71.
  6. Petrides AK, Ness MA, Judge DP, Sokoll LJ, Marzinke MA. Fluctuating creatinine in the cardiac unit. Clin Chim Acta 2015 Jul 20;447:52-4.
  7. Shah P, Zhang B, Choi C, Yang S, Zhou J, Harlan R, Tian Y, Zhang Z, Chan DW, Zhang H. Tissue proteomics using chemical immobilization and mass spectrometry. Anal Biochem 2015 Jan 15;469:27-33.
  8. Sun S, Zhang H. Large-scale measurement of absolute protein glycosylation stoichiometry. Anal Chem. 2015 Jul 7;87(13):6479-82.
  9. Thomas SN, Harlan R, Chen J, Aiyetan P, Liu Y, Sokoll LJ, Aebersold R, Chan DW, Zhang H. Multiplexed targeted mass spectrometry-based assays for the quantification of N-linked glycosite-containing peptides in serum. Anal Chem 2015 Nov 3;87(21):10830-8.
  10. Thomas SN, Zhang H, Cotter RJ. Application of quantitative proteomics to the integrated analysis of the ubiquitylated and global proteomes of xenograft tumor tissues. Clin Proteomics 2015 May 20;12(1):14.
  11. Tian Y, Almaraz RT, Choi CH, Li QK, Saeui C, Li D, Shah P, Bhattacharya R, Yarema KJ, Zhang H. Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells. Clin Proteomics 2015 Apr 11;12(1):11.
  12. Tian Y, Choi CH, Li QK, Rahmatpanah FB, Chen X, Kim SR, Veltri R, Chia D, Zhang Z, Mercola D, Zhang H. Overexpression of periostin in stroma positively associated with aggressive prostate cancer. PLoS One 2015 Mar 17;10(3):e0121502.
  13. Toghi Eshghi S, Shah P, Yang W, Li X, Zhang H. GPQuest: a spectral library matching algorithm for site-specific assignment of tandem mass spectra to intact N-glycopeptides. Anal Chem 2015 May 19;87(10):5181-8.
  14. Yang S, Chen L, Sun S, Shah P, Yang W, Zhang B, Zhang Z, Chan DW, Kass DA, van Eyk JE, Zhang H. Glycoproteins identified from heart failure and treatment models. Proteomics. 2015 Jan;15(2-3):567-79.
  15. Yang S, Mishra S, Chen L, Zhou JY, Chan DW, Chatterjee S, Zhang H. Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophy. Anal Chem 2015 Oct 6;87(19):9671-8.
  16. Yang S, Wang M, Chen L, Yin B, Song G, Turko IV,. Phinney KW, Betenbaugh MJ, Zhang H, Li S. QUANTITY: an isobaric tag for quantitative glycomics. Sci Rep 2015 Nov 30;5:17585.


  1. Bynum JP, Bishop J, Ali SZ. Cerebrospinal fluid cytology of an endolymphatic sac tumor. Diagn Cytopathol 2015 Apr;43(4):339-42.
  2. Bynum JP, Duffield A, Ali SZ. Impact of flow cytometry in liver cytopathology. Acta Cytol. 2015;59(1):51-60.
  3. Bovbel A, Zaheer A, Maleki Z. Cytomorphologic findings of intraosseous notochordal rest on touch preparation: a case report. Diagn Cytopathol 2015 Mar;43(3):243-6.
  4. Collins J, Rossi ED, Chandra A, Ali SZ. Terminology and nomenclature schemes for reporting thyroid cytopathology: an overview. Semin Diagn Pathol. 2015 Jul;32(4):258-63.
  5. Fazeli R., Schneider EB, Ali SZ, Zeiger MA, Olson MT. Diagnostic frequency ratios are insufficient to measure laboratory precision with The Bethesda System for Reporting Thyroid Cytopathology. Acta Cytologica 2015 May-June;59:225-32.
  6. Gurda GT, Zhang L, Wang Y, Chen L, Geddes S, Cho WC, Askin F, Gabrielson E, Li QK. Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases. Clin Transl Med 2015 Apr 21;4:16.
  7. Hipp J, Ali S, VandenBussche CJ. Poorly differentiated ("insular") thyroid carcinoma on fine-needle aspiration. Pathol Case Rev Oct 2015;20(5):210-3.
  8. Ho CY, VandenBussche CJ, Huppman AR, Chaudhry R, Ali SZ. Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid. Cancer Cytopathol 2015 Feb;123(2):123-35.
  9. Nagarajan N, Najafian A, Schneider EB, Zeiger MA, Olson MT. Conventional smears versus liquid-based preparations for thyroid fine-needle aspirates: a systematic review and meta-analysis. J Am Soc Cytopathol Oct 2015;253-60.
  10. Nagarajan N, Schneider EB, Ali SZ, Zeiger MA, Olson MT. How do liquid-based preparations of thyroid fine-needle aspiration compare with conventional smears? An analysis of 5475 specimens. Thyroid. 2015 Mar;25(3):308-13.
  11. Nguyen DN, Kawamoto S, Cimino-Mathews, Illei PB, Rosenthal DL, VandenBussche CJ. Metastatic metaplastic breast carcinoma mimicking pulmonary squamous cell carcinoma on fine-needle aspiration. Diagnostic Cytopathol Oct 2015;43(10):844-9.
  12. Onur I, Rosenthal DL, VandenBussche CJ. Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments. Cancer Cytopathol 2015 Mar;123(3):186-92.
  13. Onur I, Rosenthal DL, VandenBussche CJ. Benign-appearing urothelial tissue fragments in noninstrumented voided urine specimens are associated with low rates of urothelial neoplasia. Cancer Cytopathol. 2015 Mar;123(3):180-5.
  14. Sayah M, Vandenbussche C, Maleki Z. Epithelioid hemangioendothelioma in pleural effusion. Diagnostic Cytopathol Sept 2015;43(9):751-5.
  15. Uchida K, Ross H, Lotan T, Pignon JC, Signoretti S, Epstein JI, Illei PB. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity. Hum Pathol 2015 Mar;46(3):384-9.
  16. Vandenbussche CJ, Adams C, Ali SZ, Olson MT. Cytotechnologist performance for screening Hürthle cell atypia in indeterminate thyroid fine-needle aspirates. Acta Cytologica Oct 2015;59:377-83.
  17. VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P. Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs. Am J Surg Pathol. 2015 Jul;39(7):939-47.
  18. Waters KM, Ali SZ, Erozan YS, Olson MT. Smoldering medullary thyroid carcinoma liver metastasis 37 years after resection of an organ-confined tumor. Diagn Cytopathol 2015 Jan;43(1):45-8.


  1. Arnold CA, Roth R, Arsenescu R, Harzman A, Lam-Himlin DM, Limketkai BN, Montgomery EA, Voltaggio L. Sexually transmitted infectious colitis vs inflammatory bowel disease: distinguishing features from a case-controlled study. Am J Clin Pathol 2015 Nov;144(5):771-81.
  2. Ayars M, Goggins M. Pancreatic cancer: Classifying pancreatic cancer using gene expression profiling. Nat Rev Gastroenterol Hepatol 2015 Nov;12(11):613-4.
  3. Banet N, Ning Y, Montgomery EA. Inflammatory myofibroblastic tumor of the placenta: a report of a novel lesion in 2 patients. Int J Gynecol Pathol 2015 Sep;34(5):419-23.
  4. Basturk O*, Hong SM*, Wood LD*, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LAA, Fukushima N, Goggins M, Hruban RH, Kato Y, Kern SE, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJA, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 2015 Dec; 39(12):1730-41. (*equal authorship).
  5. Bhaijee F, Arnold C, Lam-Himlin D, Montgomery EA, Voltaggio L. Infectious mimics of inflammatory bowel disease. Diagnstc Histopathol 2015 July;21(7):267-75.
  6. Bhaijee F, Deyrup A, Montgomery E. Immunosupression-associated soft tissue tumors. Histopathology 2015 Nov;21(11): 432-7.
  7. Brosens LA, Hackeng WM, Offerhaus GJ, Hruban RH, Wood LD. Pancreatic adenocarcinoma pathology: changing "landscape". J Gastrointest Oncol 2015 Aug;6(4):358-74.
  8. Canto IM, Hruban RH. Diagnosis: A step closer to screening for curable pancreatic cancer? Nat Rev Gastroenterol Hepatol. 2015 Aug;12(8):431-2.
  9. Canto IM, Hruban RH. Managing pancreatic cysts: less is more? Gastroenterology. 2015 Apr;148(4):688-91.
  10. Celeiro-Muâ”ÂÂÂÂÂœâ–ÂÂÂÂÂ’oz C, Huebner TA, Robertson SA, Pittman ME, Singhi AD, Arnold CA, Bhaijee F, Voltaggio L, Montgomery EA. Tactile corpuscle-like bodies in gastrointestinal-type mucosa: a case series. Am J Surg Pathol 2015 Dec;39(12):1668-72.
  11. Dal Molin M, Zhang M, de Wilde RF, Ottenhof NA, Rezaee N, Wolfgang CL, Blackford A, Vogelstein B, Kinzler KW, Papadopoulos N, Hruban RH, Maitra A, Wood LD. Very long-term survival following resection for pancreatic cancer is not explained by commonly mutated genes: results of whole-exome sequencing analysis. Clin Cancer Res 2015 Apr 15;21(8):1944-50.
  12. Eshleman JR, Norris AL, Sadakari Y, Debeljak M, Borges M, Harrington C, Lin E, Brant A, Barkley T, Almario JA, Topazian M, Farrell J, Syngal S, Lee JH, Yu J, Hruban RH, Kanda M, Canto MI, Goggins M. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol 2015 May;13(5):963-9.
  13. Khurram M, Montgomery E. Lanthanum carbonate-associated injury to the small intestine. Daignostic Histopathology 2015 Nov;21(11):452-4.
  14. Khurram M, Xie Y, Montgomery E. Recently described and recently re-evaluated soft tissue tumours. Diagnostic Histopathology 2015 Nov;21(11):445-51.
  15. Lennon AM, Wolfgang CL, Canto MI, Klein AP, Herman JM, Goggins M, Fishman EK, Kamel I, Weiss MJ, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH. The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer Res. 2014 Jul 1;74(13):3381-9.
  16. Lin EI, Tseng LH, Gocke CD, Reil S, Le DT, Azad NS, Eshleman JR. Mutational profiling of colorectal cancers with microsatellite instability. Oncotarget 2015 Dec;6(39):42334-44.
  17. Matthaei H, Semaan A, Hruban RH. The genetic classification of pancreatic neoplasia. J Gastroenterol. 2015 May;50(5):520-32.
  18. Norris AL, Kamiyama H, Makohon-Moore A, Pallavajjala A, Morsberger LA, Lee K, Batista D, Iacobuzio-Donahue CA, Lin MT, Klein AP, Hruban RH, Wheelan SJ, Eshleman JR. Transflip mutations produce deletions in pancreatic cancer. Genes Chromosomes Cancer 2015 Aug;54(8):472-81.
  19. Norris AL, Roberts NJ, Jones S, Wheelan SJ, Papadopoulos N, Vogelstein B, Kinzler KW, Hruban RH, Klein AP, Eshleman JR. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Fam Cancer. 2015 Mar;14(1):95-103.
  20. Pea A, Hruban RH, Wood LD. Genetics of pancreatic neuroendocrine tumors: implications for the clinic. Expert Rev Gastroenterol Hepatol 2015;9(11):1407-19.
  21. Pittman ME, Brunt EM. Anatomic pathology of hepatocellular carcinoma: histopathology using classic and new diagnostic tools. Clin Liver Dis. 2015 May;19(2):239-59.
  22. Pittman ME, Montgomery EA. Distinctive clinicopathologic featuresof the common myxoid soft tissue lesions. Diagnostic Histopathology 2015 Nov;21(11):438-44.
  23. Pittman ME, Voltaggio L, Bhaijee F, Robertson SA, Montgomery EA. Autoimmune metaplastic atrophic gastritis: recognizing precursor lesions for appropriate patient evaluation. Am J Surg Pathol. 2015 Dec;39(12):1611-20.
  24. Rishi A, Goggins M, Wood LD, Hruban RH. Pathological and molecular evaluation of pancreatic neoplasms. Semin Oncol. 2015 Feb;42(1):28-39.
  25. Roberts NJ, Wolfgang CL, Wood LD, Zandi PP, Goggins M, Karchin R, Eshleman JR, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH, Klein AP. Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discov. 2016 Feb;6(2):166-75.
  26. Singhi AD, Ishida H, Ali SZ, Goggins M, Canto M, Wolfgang CL, Meriden Z, Roberts N, Klein AP, Hruban RH. A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology 2015 July-Aug;15(4):387-91.
  27. Voltaggio L, Montgomery E. Gastrointestinal tract spindle cell lesions-just like real estate, it's all about location. Mod Pathol. 2015 Jan;28 Suppl 1:S47-66.
  28. Voltaggio L, Montgomery E. Polypoid stromal lesions of the intestines. Histopathology. 2015 Jan;66(1):88-101.
  29. Wood LD, Hruban RH. Genomic landscapes of pancreatic neoplasia. J Pathol Transl Med. 2015 Jan;49(1):13-22.
  30. Yu J, Blackford A, dal Molin M, Wolfgang CL, Goggins M. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut. 2015 Nov;64(11):1783-9.


  1. Bagnasco SM, Kraus ES. Intimal arteritis in renal allografts: new takes on an old lesion. Curr Opin Organ Transplant 2015 Jun;20(3):343-7.
  2. Bezerra SM, Chaux A, Ball MW, Faraj SF, Munari E, Gonzalez-Roibon N, Sharma R, Bivalacqua TJ, Burnett AL, Netto GJ. Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas. Hum Pathol 2015 Apr;46(4):532-40.
  3. Diolombi ML, Cheng L, Argani P, Epstein JI. Do clear cell papillary renal cell carcinomas have malignant potential? Am J Surg Pathol 2015 Dec;39(12):1621-34.
  4. Epstein JI. A new contemporary prostate cancer grading system. Ann Pathol 2015 Dec;35(6):474-6.
  5. Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Cubilla AL, Shih IeM, Netto GJ. Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Hum Pathol 2015 May;46(5):761-6.
  6. Gordetsky J, Epstein JI. Intestinal metaplasia of the bladder with dysplasia: a risk factor for carcinoma? Histopathology 2015 Sep;67(3):325-30.
  7. Gordetsky J, Gorin MA, Canner J, Ball MW, Pierorazio PM, Allaf ME, Epstein JI. Frozen section during partial nephrectomy: does it predict positive margins? BJU Int. 2015 Dec;116(6):868-72.
  8. Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia MS, Goodman PJ, Lippman SM, Thompson IM, Jr., Platz EA, Meeker AK. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate. 2015 Aug;75(11):1160-6.
  9. Ide H, Miyamoto H. Steroid hormone receptor signals as prognosticators for urothelial tumor. Dis Markers Volume 2015 Dec (2015);840640:12 pages.
  10. Ishiguro H, Izumi K, Kashiwagi E, Zheng Y, Li Y, Kawahara T, Miyamoto H. Semenogelin I promotes prostate cancer cell growth via functioning as an androgen receptor coactivator and protecting against zinc cytotoxicity. Am J Cancer Res 2015 Mar; 5(2):738-47.
  11. Kalyesubula R, Lunyera J, Makanga G, Kirenga B, Amukele TK. A 4-year survey of the spectrum of renal disease at a National Referral Hospital Outpatient Clinic in Uganda. Kidney Int. 2015 Mar;87(3):663.
  12. Kawahara T, Ide H, Kashiwagi E, Patterson JD, Inoue S, Shareef HK, Aljarah AK, Zheng Y, Baras AS, Miyamoto H. Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation. Am J Cancer Res 2015 Oct;5(10):2959-68.
  13. Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Ishiguro H, Miyamoto H. The role of NFATc1 in prostate cancer progression: Cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion. Prostate 2015 May;75:573-84.
  14. Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1. Oncotarget 2015 Jan;6(3):1582-93.
  15. Kawahara T, Shareef HK, Aljarah AK, Ide H, Li Y, Kashiwagi E, Netto GJ, Zheng Y, Miyamoto H. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression. Oncotarget. 2015 Oct 6;6(30):29860-76.
  16. Khani F, Epstein JI. Prostate biopsy specimens with Gleason 3+3=6 and intraductal carcinoma: radical prostatectomy findings and clinical outcomes. Am J Surg Pathol 2015 Oct;39(10):1383-9.
  17. Kryvenko ON, Rosenberg AE, Jorda M, Epstein JI. Dedifferentiated liposarcoma of the spermatic cord: a series of 42 cases. Am J Surg Pathol 2015 Sep;39(9):1219-25.
  18. Kulac I, Haffner MC, Yegnasubramanian S, Epstein JI, De Marzo AM. Should Gleason 6 be labeled as cancer? Curr Opin Urol 2015 May;25(3):238-45.
  19. Lotan TL, Carvalho FL, Peskoe SB, Hicks JL, Good J, Fedor HL, Humphreys E, Han M, Platz EA, Squire JA, De Marzo AM, Berman DM. PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy. Mod Pathol 2015 Jan;28(1):128-37.
  20. Matoso A, Epstein JI. Epithelioid angiosarcoma of the bladder: A series of 9 cases. Am J Surg Pathol 2015 Oct;39(10):1377-82.
  21. Matoso A, Hassan O, Petrozzino F, Rao BV, Carter HB, Epstein JI. Radical prostatectomy findings in men on active surveillance: variable findings dependent on reason for surgery and entry criteria. J Urol. 2015 Sep;194(3):685-9.
  22. Morais CL, Han JS, Gordetsky J, Nagar MS, Anderson AE, Lee S, Hicks JL, Zhou M, Magi-Galluzzi C, Shah RB, Epstein JI, De Marzo AM, Lotan TL. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy. Am J Surg Pathol 2015 Feb;39(2):169-78.
  23. Morais CL, Herawi M, Toubaji A, Albadine R, Hicks J, Netto GJ, De Marzo AM, Epstein JI, Lotan TL. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas. Prostate 2015 Oct;75(14):1610-9.
  24. Munari E, Chaux A, Maldonado L, Compâ”ÂÂÂÂœęrat E, Varinot J, Bivalacqua TJ, Hoque MO, Netto GJ. Cyclin A1 expression predicts progression in pT1 Urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection. Histopathology 2015 Jan;66(2):262-9.
  25. Netto GJ. Molecular updates in prostate cancer. Surg Pathol Clinics 2015 Dec;8(4):561-80.
  26. Ozluk Y, Taheri D, Matoso A, Sanli O, Berker NK, Yakirevich E, Balasubramanian S, Ross JS, Ali SM, Netto GJ. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma. Hum Pathol 2015 Dec;46(12):1951-5.
  27. Racusen LC, Bagnasco SM. Peritubular capillaritis in the renal allograft takes center stage. Kidney Int 2015 Aug;88(2):218-20.
  28. Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol 2015 March; 11(3): 150-60.
  29. Sfanos KS, Canene-Adams K, Hempel H, Yu SH, Simons BW, Schaeffer AJ, Schaeffer EM, Nelson WG, De Marzo AM. Bacterial prostatitis enhances 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced cancer at multiple sites. Cancer Prev Res (Phila). 2015 Aug;8(8):683-92.
  30. Shah RB, Bentley J, Jeffery Z, DeMarzo AM. Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling. Hum Pathol. 2015 May;46(5):698-706.
  31. Tan HL, Haffner MC, Esopi DM, Vaghasia AM, Giannico GA, Ross HM, Ghosh S, Hicks JL, Zheng Q, Sangoi AR, Yegnasubramanian S, Osunkoya AO, De Marzo AM, Epstein JI, Lotan TL. Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas. Mod Pathol. 2015 Mar;28(3):446-56.
  32. Tian W, Epstein JI. Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases. Hum Pathol 2015 Dec;46(12):1836-41.
  33. Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto GJ. Utility of uroplakin II expression as a marker of urothelial carcinoma. Hum Pathol 2015 Jan;46(1):58-64.
  34. Tsai H, Morais CL, Alshalalfa M, Tan HL, Haddad Z, Hicks J, Gupta N, Epstein JI, Netto G, Isaacs WB, Luo J, Mehra R, Vessella RL, Karnes RJ, Schaeffer EM, Davicioni E, De Marzo A, Lotan TL. Cyclin D1 loss distinguishes prostatic small-cell carcinoma from most prostatic adenocarcinomas. Clin Cancer Res2015 Dec;21(24):5619-29.
  35. Uchida K, Ross H, Lotan T, Pignon JC, Signoretti S, Epstein JI, Illei PB. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity. Hum Pathol. 2015 Mar;46(3):384-9.
  36. Yu SH, Zheng Q, Esopi D, Macgregor-Das A, Luo J, Antonarakis ES, Drake CG, Vessella R, Morrissey C, De Marzo AM, Sfanos KS. A paracrine role for IL6 in prostate cancer patients: lack of production by primary or metastatic tumor cells. Cancer Immunol Res 2015 Oct;3(10):1175-84.
  37. Zheng Y, Ishiguro H, Ide H, Inoue S, Kashiwagi E, Kawahara T, Jalalizadeh M, Reis LO, Miyamoto H. Compound A inhibits bladder cancer growth predominantly via glucocorticoid receptor transrepression. Mol Endocrinol 2015 Oct;29(10):1486-97.
  38. Zhong M, Tian W, Zhuge J, Zheng X, Huang T, Cai D, Zhang D, Yang XJ, Argani P, Fallon JT, Epstein JI. Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. Am J Surg Pathol 2015 Jan;39(1):127-31.
  39. Wang CC, De Marzo AM, Lotan TL, Epstein JI. Overlap of CD44 expression between prostatic small cell carcinoma and acinar adenocarcinoma. Hum Pathol 2015 Apr;46(4):554-7.


  1. Banet N, Gown AM, Shih IM, Kay Li Q, Roden RB, Nucci MR, Cheng L, Przybycin CG, Nasseri-Nik N, Wu LS, Netto GJ, Ronnett BM, Vang R. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility. Am J Surg Pathol 2015 Jan;39(1):101-8.
  2. Banet N, Kurman RJ. Two types of gynecological pathology. Int J Gyn Pathol Jan 2015;34(1):3-8.
  3. Huang Z, Peng S, Knoff J, Yang B, Wu TC, Hung CF. Combination of proteasome and HDAC inhibitor enhances HPV16 E7-specific CD8+ T cell immune response and antitumor effects in a preclinical cervical cancer model. J Biomed Sci. 2015 Jan 16;22:7.
  4. Kurman RJ, Banet N. Re: Article by Natalie Banet and Robert J. Kurman: Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis; Int J Gynecol Pathol 2015;34:3-8. Int J Gynecol Pathol 2015 May;34(3):304-5.
  5. Morrison JC, Blanco LZ Jr, Vang R, Ronnett BM. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series. Am J Surg Pathol. 2015 Apr;39(4):442-53.
  6. Peng S, Wang JW, Karanam B, Wang C, Huh WK, Alvarez RD, Pai SI, Hung CF, Wu TC, Roden RB. Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer. PLoS One. 2015 Jan 5;10(1):e116389.
  7. Sun Y, Peng S, Qiu Y, Miao J, Yang B, Jeang J, Hung CF, Wu TC. Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors. Gene Ther 2015 Jul;22(7): 528-35.
  8. Wang JW, Hung CF, Huh WK, Trimble CL, Roden RB. Immunoprevention of human papillomavirus-associated malignancies. Cancer Prev Res (Phila). 2015 Feb;8(2):95-104.
  9. Wang JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Das A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RB. Seroepidemiology of human papillomavirus 16 (HPV16) L2 and generation of L2-specific human chimeric monoclonal antibodies. Clin Vaccine Immunol. 2015 Jul;22(7):806-16.
  10. Wang JW, Jiang R, Peng S, Chang YN, Hung CF, Roden RB. Immunologic control of Mus musculus papillomavirus type 1. PLoS Pathog 2015 Oct 23;11(10):e1005243.
  11. Wang Y, Shwartz LE, Anderson D, Lin MT, Haley L, Wu RC, Vang R, Shih IeM, Kurman RJ. Molecular analysis of ovarian mucinouscarcinoma reveals different cell of origins. Oncotarget 2015 Sep 8;6(26):22949-58.
  12. Wang Y, Wu RC, Shwartz, Haley L, Lin MT, Shih IeM, Kurman RJ. Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin. J Pathol. 2015 Oct;237(2):146-51.
  13. Yang B, Yang A, Peng S, Pang X, Roden RB, Wu TC, Hung CF. Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination. Cell Biosci 2015 Jun 25;5:35.
  14. Yu Y, Gaillard S, Phillip JM, Huang TC, Pinto SM, Tessarollo NG, Zhang Z, Pandey A, Wirtz D, Ayhan A, Davidson B, Wang TL*, Shih IeM*. Inhibition of spleen tyrosine kinase potentiates paclitaxel-induced cytotoxicity in ovarian cancer cells by stabilizing microtubules. Cancer Cell 2015 Jul;28(1):82-96.


  1. Borowitz MJ, Wood BL, Devidas M, Loh ML, Raetz EA, Salzer WL, Nachman JB, Carroll AJ, Heerema NA, Gastier-Foster JM, Willman CL, Dai Y, Winick NJ, Hunger SP, Carroll WL, Larsen E. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. Blood. 2015 Aug 20;126(8):964-71.
  2. Crane GM, Powell H, Kostadinov R, Rocafort PT, Rifkin DE, Burger PC, Ambinder RF, Swinnen LJ, Borowitz MJ, Duffield AS. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage. Oncotarget 2015 Oct 20;6(32):33849-66.
  3. Kern JB, Hii A, Kruse MJ, Szabo Z, Argani P, Hibbard MK, Gladstone DE, Meyer C, Zheng R, Borowitz MJ, Duffield AS. A Leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor. Int J Surg Pathol 2015 Feb;23(1):757.
  4. Rodić N, Steranka JP, Makohon-Moore A, Moyer A, Shen P, Sharma R, Kohutek ZA, Huang CR, Ahn D, Mita P, Taylor MS, Barker NJ, Hruban RH, Iacobuzio-Donahue CA, Boeke JD, Burns KH. Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma. Nat Med 2015 Sep;21(9):1060-4.
  5. Su M, Alonso S, Jones JW, Yu J, Kane MA, Jones RJ, Ghiaur G. All-trans retinoic acid activity in acute myeloid leukemia: role of cytochrome P450 enzyme expression by the microenvironment. PLoS One 2015 Jun 5;10(6):e0127790.


  1. Amukele TK, Schroeder LF, Jackson JB, Elbireer A. Most clinical laboratory testing in Kampala occurs in high-volume, high-quality laboratories or low-volume, low-quality laboratories. A tale of two cities. Am J Clin Pathol 2015 Jan;143(1):50-6.
  2. Amukele T, Sokoll LJ, Pepper D, Howard DP, Street J. Can unmanned aerial systems (drones) be used for the routine transport of chemistry, hematology, and coagulation laboratory specimens? PLoS One. 2015 Jul 29;10(7):e0134020.
  3. Dai H, Rahman A, Saxena A, Jaiswal AK, Mohamood A, Ramirez L, Noel S, Rabb H, Jie C, Hamad AR. Syndecan-1 identifies and controls the frequency of IL-17-producing naïve natural killer T (NKT17) cells in mice. Eur J Immunol 2015 Nov;45(11):3045-51.
  4. De Remigis A, de Gruijl TD, Uram JN, Tzou SC, Iwama S, Talor MV, Armstrong TD, Santegoets SJ, Slovin SF, Zheng L, Laheru DA, Jaffee EM, Gerritsen WR, van den Eertwegh AJ, Le DT, Caturegli P. Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival. Int J Cancer. 2015 Jan 1;136(1):127-37.
  5. Fontes JA, Rose NR, Čiháková D. The varying faces of IL-6: from cardiac protection to cardiac failure. Cytokine. 2015 Jul;74(1):62-68.
  6. Kim AR, Sadegh-Nasseri S. Determinants of immunodominance for CD4 T cells. Curr Opin Immonol 2015 June;34:9-15.
  7. Martina MN, Noel S, Saxena A, Rabb H, Hamad AR. Double negative (DN) αβ T cells: misperception and overdue recognition. Immunol Cell Biol 2015 Mar;93(3):305-10.
  8. Nagineni CN, Kommineni VK, Ganjbaksh N, Nagineni KK, Hooks JJ, Detrick B. Inflammatory cytokines induce expression of chemokines by human retinal cells: role in chemokine receptor mediated age-related macular degeneration. Aging Dis 2015 Nov 17;6(6):444-55.
  9. Ong S, Ligons DL, Barin JG, Wu L, Talor MV, Diny N, Fontes JA, Gebremariam E, Kass DA, Rose NR, Čiháková D. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am J Pathol 2015 Mar;185(3):847-61.
  10. Peterson DA, Planer JD, Guruge JL, Xue L, Downey-Virgin W, Goodman AL, Seedorf H, Gordon JI. Characterizing the interactions between a naturally primed immunoglobulin A and its conserved bacteroides thetaiotaomicron species-specific epitope in gnotobiotic mice. J Biol Chem 2015 May 15;290(20):12630-49.
  11. Perica K, Bieler JG, Schütz C, Varela JC, Douglass J, Skora A, Chiu YL, Oelke M, Kinzler K, Zhou S, Vogelstein B, Schneck JP. Enrichment and expansion with nanoscale artificial antigen presenting cells for adoptive immunotherapy. ACS Nano 2015 Jul 28;9(7):6861-71.
  12. Perica K, Kosmides AK, Schneck JP. Linking form to function: Biophysical aspects of artificial antigen presenting cell design. Biochim Biophys Acta 2015 Apr;1853(4):781-90.
  13. Ramirez L, Hamad AR. From non-obese diabetic to Network for the Pancreatic Organ Donor with Diabetes: New heights in type 1 diabetes research. World J Diabetes 2015 Nov 25;6(16):1309-11.
  14. Rose NR. In the Beginning. Focus IMAJ 2015 Feb;17:74-9.
  15. Rose NR. Molecular mimicry and clonal deletion: a fresh look. J Theor Biol 2015 Jun 21;375:71-6.
  16. Sadegh-Nasseri S, Kim A. Exogenous antigens bind MHC class II first, and are processed by cathepsins later. Mol Immunol 2015 Dec;68(2 Pt A):81-4.
  17. Sadegh-Nasseri S, Kim A. MHC Class II Auto-antigen processing and presentation is unconventional. Front Immunol 2015 Jul 22;6:372.
  18. Saxena A, Khosraviani S, Noel S, Mohan D, Donner T, Hamad AR. Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine. 2015 Jul;74(1):27-34.
  19. 19. Schroeder LF, Elbireer A, Jackson JB, Amukele TK. Laboratory diagnostics market in East Africa: a survey of test types, test availability, and test prices in Kampala, Uganda. PLoS One 2015 Jul 30;10(7):e0134578.


  1. Lai S, Gerstenblith G, Li J, Zhu H, Bluemke DA, Liu C-Y, Zimmerman SL, Chen S, Lai H, Treisman G. Chronic cocaine use and its association with myocardial steatosis evaluated by 1H magnetic resonance spectroscopy in African Americans. J Addict Med 2015 Jan-Feb 9(1):31-9.
  2. Lai H, Stitzer M, Treisman G, Moore R, Brinker J, Gerstenblith G, Kickler TS, Li J, Chen S, Fishman E, Lai S. Cocaine abstinence and reduced use associated with lowered marker of endothelial dysfunction in African Americans: a preliminary study. J Addict Med 2015 Jul-Aug;9(4):331-9.


  1. Burbulis IE, Yamaguchi K, Nikolskaia OV, Prigge ST, Magez S, Bisser S, Reller ME, Grab DJ. Detection of pathogen-specific antibodies by loop-mediated isothermal amplification. Clin Vaccine Immunol 2015 Apr;22(4):374-80.
  2. Farley JE, Hayat MJ, Sacamano PL, Ross T, Carroll K. Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in an HIV-positive cohort. Am J Infect Control 2015 Apr 1;43(4):329-35.
  3. Greer AE, Forman MS, Valsamakis A. Comparison of BKV quantification using a single automated nucleic acid extraction platform and 3 real-time PCR assays. Diagn Microbiol Infect Dis 2015 Aug;82(4):297-302.
  4. Kiweewa FM, Bakaki PM, McConnell MS, Musisi M, Namirembe C, Nakyiwa F, Kusasira F, Nakintu D, Ssemuwenba A, Mubiru M, Musoke P, Fowler MG. A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, "the Nevirapine Repeat Pregnancy study". BMC Public Health 2015 Sept:15;988.
  5. Lyons JL, Thakur KT, Lee R, Watkins T, Pardo CA, Carson KA, Markley B, Finkelman MA, Marr KA, Roos KL, Zhang SX. Utility of measuring (1,3) Β-D-glucan in cerebrospinal fluid for the diagnosis of fungal central nervous system infection. J Clin Microbiol 2015 Jan;53(1):319-22.
  6. Riedel S, Ross JE, Farrell DJ, Flamm RK, Jones RN. Determination of disk diffusion and MIC quality control guidelines for solithromycin, a novel fluoroketolide antibacterial against Neisseria gonorrhoeae. J Clin Microbiol 2015 Dec;53(12):3888-90.
  7. Sumpio BJ, Chitragari G, Moriguchi T, Shalaby S, Pappas-Brown V, Khan AM, Sekaran SD, Sumpio BE, Grab DJ. African Trypanosome-induced blood-brain barrier dysfunction under shear stress may not require ERK activation. Int J Angiol 2015 Mar;24(01):41-6.
  8. Suwantarat N, Adams LL, Romagnoli M, Carroll KC. Fatal case of Herbaspirillum seropedicae bacteremia secondary to pneumonia in an end-stage renal disease patient with multiple myeloma. Diagn Microbiol Infect Dis 2015 Aug;82(4):331-3.
  9. Suwantarat N, Dalton JB, Lee R, Green R, Memon W, Carroll KC, Riedel S, Zhang SX. Large-scale clinical validation of a lateral flow immunoassay for detection of cryptococcal antigen in serum and cerebrospinal fluid specimens. Diagn Microbiol Infect Dis 2015 May;82(1):54-6.
  10. Suwantarat N, Grundy M, Rubin M, Harris R, Miller JA, Romagnoli M, Hanlon A, Tekle T, Ellis BC, Witter FR, Carroll KC. Recognition of streptococcus pseudoporcinus colonization in women as a consequence of using matrix-assisted laser desorption ionization-time of flight mass spectrometry for group B streptococcus identification. J Clin Microbiol 2015 Dec;53(12):3926-30.


  1. Chen G, Dudley J, Tseng LH, Smith K, Gurda GT, Gocke CD, Eshleman JR, Lin MT. Lymph node metastases of melanoma: challenges for BRAF mutation detection. Hum Pathol 2015 Jan;46(1):113-9.
  2. Dudley J, Tseng LH, Rooper L, Harris M, Haley L, Chen G, Gocke CD, Eshleman JR, Lin MT. Challenges posed to pathologists in the detection of KRAS mutations in colorectal cancers. Arch Pathol Lab Med 2015 Feb;139(2):211-8.
  3. Gold B, Cankovic M, Furtado LV, Meier F, Gocke CD. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the Association for Molecular Pathology. J Mol Diagn May 2015;17(3):209-24.
  4. Haley L, Tseng LH, Zheng G, Dudley J, Anderson DA, Azad NS, Gocke CD, Eshleman JR, Lin MT. Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers. Mod Pathol 2015 Oct;28(10):1390-9.
  5. Jhaveri TZ, Woo J, Shang X, Park BH, Gabrielson E. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer. Oncotarget 2015 Jun 20;6(17):14754-65.
  6. Lin MT, Tseng LH, Dudley J, Riel S, Tsai H, Zhen G, Pratz KW, Levis M, Gocke CD. A novel tandem duplication assay to detect minimal residual disease in FLT3/ITD AML. Molecular Diagnosis & Therapy 2015 Dec;19(6):409-17.
  7. Nauen DW, Guajardo A, Haley L, Powell K, Burger PC, Gocke CD. Chromosomal defects track tumor subpopulations and change in progression in oligodendroglioma. Coverg Sci Phys Oncol 2015 June;1(1):015001.
  8. Weiss K, Applegate C, Wang T, Batista DA. Familial TAB2 microdeletion and congenital heart defects including unusual valve dysplasia and tetralogy of fallot. Am J Med Genet A 2015 Nov;167(11):2702-6.
  9. Xi Y, Li J, Zhang P, Bai W, Gao N, Bai W, Zhang Y, Wu Y, Ning Y. Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma. Exp Mol Pathol. 2015 Oct;99(2):297-302.
  10. Zheng G, Tseng LH, Chen G, Haley L, Illei P, Gocke CD, Eshleman JR, Lin MT. Clinical detection and categorization of uncommon and concomitant mutations involving BRAF. BMC Cancer 2015 Oct;15:779.


  1. Brandt WD, Schreck KC, Bar EE, Taylor I, Marchionni L, Raabe E, Eberhart CG, Rodriguez FJ. Notch signaling activation in pediatric low-grade astrocytoma. J Neuropathol Exp Neurol 2015 Feb;74(2):121-31.
  2. Eberhart CG, Orr BA. Molecular pathways: not a simple tube-the many functions of blood vessels. Clin Cancer Res 2015 Jan;21(1):18-23.
  3. Ho CY, Mobley BC, Gordish-Dressman H, VandenBussche CJ, Mason GE, Bornhorst M, Esbenshade AJ, Tehrani M, Orr BA, LaFrance DR, Devaney JM, Meltzer BW, Hofherr SE, Burger PC, Packer RJ, Rodriguez FJ. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation. Acta Neuropathol. 2015 Oct;130(4):575-85.
  4. Ho CY, Mosier S, Safneck J, Salomao DR, Miller NR, Eberhart CG, Gocke CD, Batista DA, Rodriguez FJ. Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma. Brain Pathol 2015 Mar;25(2):193-201.
  5. Iacono D, Zandi P, Gross M, Markesbery WR, Pletnikova O, Rudow G, Troncoso JC. APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study. Oncotarget. 2015 Jun 10;6(16):14082-91.
  6. Kahlert UD, Suwala AK, Koch K, Natsumeda M, Orr BA, Hayashi M, Maciaczyk J, Eberhart CG. Pharmacologic Wnt inhibition reduces proliferation, survival, and clonogenicity of glioblastoma cells. J Neuropathol Exp Neurol. 2015 Sep;74(9):889-900.
  7. Kahlert UD, Suwala AK, Raabe EH, Siebzehnrubl FA, Suarez MJ, Orr BA, Bar EE, Maciaczyk J, Eberhart CG. ZEB1 promotes invasion in human fetal neural stem cells and hypoxic glioma neurospheres. Brain Pathol 2015 Nov;25(6):724-32.
  8. Lauterbach MD, Notarangelo PL, Lane KS, Koliatsos VE. Treatment of traumatic brain injury-induced dyskinesia with tetrabenazine: a case report. Psychosomatics 2015 Sep-Oct;56(5):567-71.
  9. Lim KJ, Brandt WD, Heth JA, Muraszko KM, Fan X, Bar EE, Eberhart CG. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget 2015 Jan 30;6(3):1666-77.
  10. Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 2015 Aug 7;349(6248):650-5.
  11. Pletnikova O, Rudow GL, Hyde TM, Kleinman JE, Ali SZ, Bharadwaj R, Gangadeen S, Crain BJ, Fowler DR, Rubio AI, Troncoso JC. Alzheimer lesions in the autopsied brains of people 30 to 50 years of age. Cogn Behav Neurol. 2015 Sep;28(3):144-52.
  12. Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 2015 Apr;129(4):609-10.
  13. Savonenko AV, Melnikova T, Wang Y, Ravert H, Gao Y, Koppel J, Lee D, Pletnikova O, Cho E, Sayyida N, Hiatt A, Troncoso J, Davies P, Dannals RF, Pomper MG, Horti AG. Cannabinoid CB2 receptors in a mouse nodel of Αβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation. PLoS One. 2015 Jun 18;10(6):e0129618.
  14. Shyam R, Ren Y, Lee J, Braunstein KE, Mao HQ, Wong PC. Intraventricular delivery of siRNA nanoparticles to the central nervous system. Mol Ther Nucleic Acids 2015 May 12;4:e242.
  15. Sun M, Oulabi I, Chen L. CRISPR/Cas9 genome editing system in Drosophila. Adv Tech Biol Med 2015 Sept;S1:003.
  16. Sun M, Chen L. Studying tauopathies in Drosophila: a fruitful model. Exp Neurol. 2015 Dec;274(Pt A):52-7.
  17. Vizcaíno MA, Shah S, Eberhart CG, Rodriguez FJ. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas. Hum Pathol 2015 Sep;46(9):1323-30.
  18. Xu L. Animal model of repetitive mild traumatic brain injury for human traumatic axonal injury and chronic traumatic encephalopathy. Neural Regen Res 2015 Dec;10(11):1731-2


  1. Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG. EMT-associated factors promote invasive properties of uveal melanoma cells. Mol Vis. 2015 Aug 25;21:919-29.
  2. Suarez MJ, River-Michlig R, Dubovy S, Rodriguez F. Clinicopathological features of ophthalmic neoplasms arising in the setting of xeroderma pigmentosum. Ocul Oncol Pathol 2016 Dec 2015;2:112-21.


  1. Argani P. MiT family translocation renal cell carcinoma. Semin Diagn Pathol 2015 Mar;32(2):103-13.
  2. Argani P, Lewin JR, Edmonds P, Netto GJ, Prieto-Granada C, Zhang L, Jungbluth AA, Antonescu CR. Primary renal sclerosing epithelioid fibrosarcoma: report of 2 cases with EWSR1-CREB3L1 gene fusion. Am J Surg Pathol 2015 Mar;39(3):365-73.
  3. Baras AS, Gandhi N, Munari E, Faraj S, Shultz L, Marchionni L, Schoenberg M, Hahn N, Hoque M, Berman D, Bivalacqua TJ, Netto G. Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma. PLoS One 2015 Jul 31;10(7):e0131245.
  4. Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015 Sep;39(9):1267-74.
  5. Bishop JA, Lewis JS Jr, Rocco JW, Faquin WC. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice. Semin Diagn Pathol 2015 Sep;32(5):344-51.
  6. Bishop JA, Thompson LD, Cardesa A, Barnes L, Lewis JS Jr, Triantafyllou A, Hellquist H, Stenman G, Hunt JL, Williams MD, Slootweg PJ, Devaney KO, Gnepp DR, Wenig BM, Rinaldo A, Ferlito A. Rhabdomyoblastic differentiation in head and neck malignancies other than rhabdomyosarcoma. Head Neck Pathol 2015 Dec;9(4):507-18.
  7. Bishop JA, Westra WH. Ciliated HPV-related carcinoma: a well-differentiated form of head and neck carcinoma that can be mistaken for a benign cyst. Am J Surg Pathol 2015 Nov;39(11):1591-5.
  8. Bishop JA, Yonescu R, Epstein JI, Westra WH. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma. Hum Pathol 2015 Aug;46(8):1204-8.
  9. Cimino-Mathews A, Foote JB, Emens LA. Immune targeting in breast cancer. Oncology (Williston Park) 2015 May;29(5):375-85.
  10. Gorin MA, Rowe SP, Allaf ME, Argani P. Angiomyolipoma with epithelial cysts: Add one to the differential of cystic renal lesions. Int J Urol 2015 Nov;22(11):1081-2.
  11. Heaphy CM, Asch-Kendrick R, Argani P, Meeker AK, Cimino-Mathews A. Telomere length alterations unique to invasive lobular carcinoma. Hum Pathol. 2015 Aug;46(8):1197-203.
  12. Holmes BJ, Maleki Z, Westra WH. The fidelity of p16 staining as a surrogate Marker of human papillomavirus status in fine-needle aspirates and core biopsies of neck node metastases: implications for HPV testing protocols. Acta Cytol 2015;59(1):97-103.
  13. Miller PD, McCarthy EF. Bisphosphonate-associated atypical sub-trochanteric femur fractures: Paired bone biopsy quantitative histomorphometry before and after teriparatide administration. Semin Arthritis Rheum. 2015 Apr;44(5):477-82.
  14. Rooper L, Sharma R, Bishop JA. Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma. Head Neck Pathol 2015 Mar;9(1):79-84
  15. Smith NE, Epstein JI, Parwani AV, Netto GJ, Illei PB, Powell K, Allaf ME, Argani P. Smooth muscle and adenoma-like renal tumor: a previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm? Hum Pathol. 2015 Jun;46(6):894-905.
  16. VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P. Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs. Am J Surg Pathol 2015 Jul;39(7):939-47.


  1. Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. Antiretroviral drug use and HIV drug resistance among HIV-infected Black men who have sex with men: HIV Prevention Trials Network 061. J Acquir Immune Defic Synd. 2015 Aug;69(4):446-52.
  2. Chen I, Ou S-S, Marzinke MA, Breaud A, Hughes JP, Richardson, P, Haley DF, Lucas J, Rompalo A, Justman JE, Hodder SA, Eshleman SH. Antiretroviral drug use in a cohort of HIV-uninfected women in the United States: HIV Prevention Trials Network 064. PLoS One 2015 Oct 7;10(10):e0140074.
  3. Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Determination of HIV status in African adults with discordant HIV rapid tests. J Acquir Immune Defic Syndr 2015 Aug;69(4):430-8.
  4. Goel R, Ness PM, Takemoto C, King KE, Krishnamurti L, Tobian AAR. Platelet transfusions in platelet consumptive disorders are associated with in-hospital arterial thrombotic complications and mortality. Blood 2015; 125(9):1470-6.
  5. Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR. Use of injectable hormonal contraception and women's risk for herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda. Lancet Global Health 2015 Aug;3:e478-86.
  6. Grabowski MK, Kigozi G, Gray RH, Armour B, Manucci J, Serwadda D, Redd AD, Nalugoda Patel EU, Wawer MJ, Quinn TC, Tobian AAR. Herpes simplex virus type 2 shedding from male circumcision wounds in Rakai Uganda. J Infect Dis 2015 Nov 15;212(10):1613-7.
  7. Kacker S, Ness PM, Shirey RS, Savage WJ, King KE, Tobian AAR. The future of red blood cell alloimmunization risk reduction. Transfusion 2015 Jan;55(1):222-4.
  8. Kacker S, Vassallo R, Keller MA, Westhoff CM, Frick KD, Sandler SG, Tobian AA. Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype. Transfusion. 2015 Sep;55(9):2095-103.
  9. Kantor R, Smeaton L, SH Eshleman: AIDS Clinical Trials Group (ACTG) A5175 Study Team. Pre-treatment HIV drug resistance and HIV-1 subtype Care independently associated with virologic failure: Results from the multi-national PEARLS (ACTG A5175) clinical trial. Clin Infect Dis 2015 May;60(10):1541-9.
  10. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, Cipolle MD, Cohn CS, Fung MK, Grossman BJ, Mintz PD, O'Malley BA, Sesok-Pizzini DA, Shander A, Stack GE, Webert KE, Weinstein R, Welch BG, Whitman GJ, Wong EC, Tobian AAR. Platelet transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2015 Feb;162:205-13.
  11. Ness PM, English J. TRANSFUSION enhancements in the digital age. Transfusion 2015 Jan;55(1):10.
  12. Ness PM, Frank SM. Enhancing patient blood management: a long term FOCUS. The Lancet 2015 Mar;385(9974):1157-9.
  13. Pagano MB, Ness PM, Chajewski OS, King KE, Wu Y, Tobian AA. Hypotensive transfusion reactions in the era of prestorage leukoreduction. Transfusion 2015 Jul;55(7):1668-74.
  14. Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke M, Fiamma A, Donnell D, Kulich M, Mbwambo JKK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Africa. J Clin Virol 2015 Jan;62:75-9.
  15. Tobian AAR, Adamu T, Reed J, Kiggundu V, Yazdi Y, Njeuhmeli E. Voluntary medical male circumcision: moving from evidence to policy to scale-up in resource constrained settings. Nature Reviews Urology Dec 2015;12:661-70.
  16. Tobian AAR, Kigozi G, Manucci J, Grabowski MK, Serwadda D, Musoke R, Redd AD, Nalugoda F, Reynolds SJ, Kighoma N, Laeyendecker O, Lessler J, Gray RH, Quinn TC, Wawer MJ and the Rakai Health Sciences Program. HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study. PLoS Medicine 2015;12(4):e1001820.
  17. Westhoff CM, Ness PM. The promise of extended donor antigen typing. Transfusion. 2015 Nov;55(11):2541-3.
  18. White MJ, Hazard SW 3rd, Frank SM, Boyd JS, Wick EC, Ness PM, Tobian AA. The evolution of perioperative transfusion testing and blood ordering. Anesth Analg 2015 Jun;120(6):1196-203.
  19. Yang B, Yang A, Peng S, Pang X, Roden RB, Wu TC, Hung CF. Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination. Cell Biosci 2015 Jun 25;5:35.


  1. Caturegli P, McCarthy EF, Jackson BJ, Hruban RH. The Pathology residency program of the Johns Hopkins University School of Medicine: a model of its kind. Arch Pathol Lab Med 2015 Mar;139:400-6.